Antineoplastic AgentsDrug Screening Assays, AntitumorCell Line, TumorNeoplasmsApoptosisAntineoplastic Agents, PhytogenicXenograft Model Antitumor AssaysDrug Resistance, NeoplasmInhibitory Concentration 50Antibiotics, AntineoplasticMice, NudeDoxorubicinCell SurvivalCell ProliferationTumor Cells, CulturedMolecular StructureDrug DesignDrug Delivery SystemsCamptothecinClinical Trials, Phase I as TopicTopoisomerase I InhibitorsDose-Response Relationship, DrugCisplatinCell CycleDrug SynergismTopoisomerase InhibitorsEnzyme InhibitorsTubulin ModulatorsEtoposidePlant ExtractsProdrugsDrug Resistance, MultiplePaclitaxelAnticarcinogenic AgentsDrugs, InvestigationalDrug CarriersHistone Deacetylase InhibitorsHT29 CellsColonic NeoplasmsStructure-Activity RelationshipHCT116 CellsP-GlycoproteinDrug Evaluation, PreclinicalCaspasesBreast NeoplasmsCell DivisionDNA DamageEllipticinesPlatinumDNA Topoisomerases, Type IINeoplasm TransplantationGene Expression Regulation, NeoplasticAntimetabolites, AntineoplasticKB CellsLung NeoplasmsSignal TransductionCaspase 3Molecular Targeted TherapyBiological ProductsLeukemia L1210Tumor Suppressor Protein p53Neoplasms, ExperimentalRazoxaneTransplantation, HeterologousTopoisomerase II InhibitorsThiosemicarbazonesHydroxamic AcidsIntercalating AgentsCell DeathAntineoplastic Agents, AlkylatingAnthracyclinesMCF-7 CellsSulfonamidesBenzoquinonesDaunorubicinIndolesPhytotherapyProto-Oncogene Proteins c-bcl-2Angiogenesis InhibitorsDepsipeptidesClinical Trials as TopicCurcuminNanocapsulesLeukemia P388Blotting, WesternNanoparticlesMaleic AnhydridesCell Growth ProcessesOrganoplatinum CompoundsDNA Topoisomerases, Type IFluorouracilSesquiterpenesNaphthalimidesTeniposideXanthonesCoordination ComplexesCell Cycle CheckpointsNeoplasm ProteinsTumor BurdenG2 Phase